[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100337803":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":31,"responsibleParty":52,"collaborators":18,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":18,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":78,"overallStatus":34,"whyStopped":18,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Centre Hospitalier Charles Perrens, Bordeaux","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Smartphone application","EXPERIMENTAL","This group of subjects receives mobile support system and conventional treatment (clinical evaluation and follow-up). The smartphone application will be downloaded on patients' smartphone to daily evaluate symptomatology, medication adherence…",[13],"Device: Smartphone Support System",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard services","NO_INTERVENTION","This group of patients receives conventional treatment only. Clinical evaluations are provided at the same endpoint. Patients still receive standard services for depression.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","Smartphone Support System","6 weeks smartphone application with daily evaluations",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"David MISDRAHI, M.D","CONTACT","+33(0)556563449","dmisdrahi@ch-perrens.fr",[32],{"facility":33,"status":34,"city":35,"state":18,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Centre Hospitalier Charles PERRENS","RECRUITING","Bordeaux","33076","France","FR",{"type":40,"coordinates":41},"Point",[42,43],-0.58046,44.84124,{"lat":43,"lon":42},[46,48],{"name":27,"role":28,"phone":47,"phoneExt":18,"email":30},"003356563449",{"name":49,"role":28,"phone":50,"phoneExt":18,"email":51},"Helen SAVARIEAU, MSc","003356563556","hsavarieau@ch-perrens.fr",{"type":53,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100337803","treating-depression-on-a-day-to-day-basis-development-of-a-tool-for-physicians-based-on-a-smartphone-application-100337803",false,"NCT03678194","Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application","Treating Depression on a Day-to-day Basis: Development of a Novel Clinical Tool for Physicians Based on a Smartphone Application, the SMART Project (Smartphones and Mood Disorders, an Application for Research and Treatment)","SMART","Inclusion Criteria:\n\n* Age between 18 and 65 years;\n* Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of depression assessed by the Structured Clinical Interview;\n* Patients started their antidepressant treatment less than 5 days before inclusion;\n* Patient treated in an outpatient setting;\n* Patient informed of the diagnosis of his disease;\n* Informed patient with written consent.\n\nExclusion Criteria:\n\n* A current mental or psychiatric impairment or disease (schizophrenia, bipolar disorder) that required psychotropic medication or inpatient treatment on a psychiatric ward;\n* A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features;\n* Cognitive deficit and not thus being able to comprehend the informed consent and study procedure;\n* Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy….);\n* Non-comprehension of the French language","ALL","18 Years","65 Years",{"count":66,"type":67},200,"ESTIMATED","INTERVENTIONAL",[70],"NA","Testing and validating an e-health (smartphone application) approach to better understand the determinants of day-to-day symptomatology in depression, medication adherence, and treatment efficacy in the goal of maximizing patient care.",[73,74,75,76,77],"Depression","Psychiatric Disorder","Brain Diseases","Central Nervous System Diseases","Nervous System Diseases",[73,79,80,81,82,83,84,85],"Smartphone","Relapse prevention","Mobile support system","eHealth","Ecological","Randomized","Multicentric","2026-03-13",{"date":88,"type":89},"2026-03-16","ACTUAL",{"date":91,"type":89},"2020-10-14",{"date":93,"type":67},"2026-12-31",{"name":5,"class":6},1]